Rat BMP_2 ELISA kit
- Known as:
- Rat BMP_2 Enzyme-linked immunosorbent assay test reagent
- Catalog number:
- LF-EK50505
- Product Quantity:
- 1×96T
- Category:
- Peptides
- Supplier:
- Abfron
- Gene target:
- Rat BMP_2 ELISA kit
Related genes to: Rat BMP_2 ELISA kit
- Gene:
- BMP2 NIH gene
- Name:
- bone morphogenetic protein 2
- Previous symbol:
- BMP2A
- Synonyms:
- -
- Chromosome:
- 20p12.3
- Locus Type:
- gene with protein product
- Date approved:
- 1990-06-11
- Date modifiied:
- 2016-10-05
- Gene:
- BMP4 NIH gene
- Name:
- bone morphogenetic protein 4
- Previous symbol:
- BMP2B
- Synonyms:
- -
- Chromosome:
- 14q22.2
- Locus Type:
- gene with protein product
- Date approved:
- 1990-06-11
- Date modifiied:
- 2016-10-05
Related products to: Rat BMP_2 ELISA kit
Human ELC ELISA KIT 96 TEST
OxiSelect In Vitro ROS/RNS Assay Kit (Green Fluorescence), Trial Size
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect TBARS Assay Kit (MDA Quantitation), Trial Size
OxiSelect Total Antioxidant Capacity (TAC) Assay Kit, Trial Size
OxiSelect™ In Vitro ROS RNS Assay Kit (Green Fluorescence), Trial Sizeα - Calcitonin Gene Related Peptide, α - CGRP, rat'F 4_80 Antigen (mouse) Host Rat'F 4_80 Antigen (mouse) Host Rat(1-3)-beta-D-glucan Sandwich ELISA, Double Antibody(1-Kit )11,12-EET DHET Immunoassay Kit(1-Kit )11,12-EET_DHET Immunoassay Kit(1-Kit) 11,12-DHET Immunoassay Kit(1-Kit) 14,15-DHET Human Urine ELISA Kit Related articles to: Rat BMP_2 ELISA kit
- Fasting-induced molting is widely employed in the poultry industry to rejuvenate the reproductive system of aging laying hens, thereby improving post-molt laying performance and extending productive lifespan. However, substantial individual variation in post-molt reproductive recovery may compromise the overall effectiveness of molting programs. Elucidating the molecular basis underlying this variation is therefore important for poultry production and genetic improvement. In this study, laying hens were classified into high-recovery (HR) and low-recovery (LR) groups according to their egg production recovery following fasting-induced molting. Transcriptomic profiling of the hypothalamus, pituitary, ovary, and liver was performed using RNA sequencing (RNA-seq). A total of 271, 435, 3,425, and 289 differentially expressed genes (DEGs) were identified between the HR and LR groups in the hypothalamus, pituitary, ovary, and liver, respectively. Functional enrichment analysis showed that these DEGs were primarily associated with protein homeostasis, hormone response, ribosome function, and immune regulation, indicating distinct tissue-specific biological functions during post-molt recovery. Integration of weighted gene co-expression network analysis (WGCNA) and protein-protein interaction (PPI) network analysis further identified HSP90AA1, GDF7, CTSS, and STS as candidate hub genes associated with post-molt reproductive recovery. Collectively, this study provides a comprehensive multi-tissue transcriptomic landscape of post-molt egg production recovery and identifies key biological processes and candidate genes potentially involved in this process. These findings improve our understanding of the molecular mechanisms underlying post-molt reproductive recovery and provide valuable genetic resources for the genetic improvement of laying hens with superior post-molt performance. - Source: PubMed
Publication date: 2026/09/15
Miao XiaomengLiu JiaLi FuguiChen XingWei YiminZhang LiFeng YulongNing Zhonghua - Recent studies have shown that UFMylation plays an important role in cancer, but its specific function in gastric cancer (GC) remains to be fully elucidated. This study aimed to develop a prognostic signature based on UFMylation-related genes (URGs) for survival prediction in GC. - Source: PubMed
Publication date: 2026/07/27
Chen GuohaoGao XianDai LingchenDeng ShukangWang HaoyangHuang XinkunFeng Ying - Intervertebral disc degeneration (IVDD) is characterized by excessive inflammation and extracellular matrix (ECM) degradation in the nucleus pulposus (NP), with limited current therapeutic options. Specialized pro-resolving mediators (SPMs) such as Maresin 1 (MaR1) have emerged as key regulators of inflammation resolution and tissue repair. Here, we report that MaR1 and its receptor LGR6 are significantly downregulated in degenerated human NP tissues, suggesting a loss of endogenous resolution capacity. Exogenous MaR1 administration effectively attenuated IL-1β-induced inflammation and ECM degradation in human NP cells and alleviated IVDD progression in rat models. Mechanistically, MaR1 simultaneously suppressed the catabolic AP-1/MMP pathway and activated the pro-anabolic OSR1/GDF7 axis, rebalancing ECM homeostasis. Notably, the therapeutic efficacy of MaR1 was completely abrogated in Lgr6-knockout mice, demonstrating that LGR6 is the indispensable mediator of MaR1's protective effects in vivo. Our findings identify the MaR1-LGR6 axis as a critical regulator of disc homeostasis and highlight MaR1 supplementation as a novel and promising strategy for IVDD treatment. - Source: PubMed
Publication date: 2026/08/07
Wang HuiLi XiangyuYan TaoHe PanweiYao JunxiangWang JinhuiSu LeleWu AiminJin ShengweiWang JianguangLv Chen - House dust mite (HDM) is a major global inducer of allergic asthma, yet its epigenetic impact on airway tissues remains poorly understood. The aim of this study was to perform an exploratory, hypothesis-generating screening of the DNA methylation changes that occur in lung tissue of mice with robust allergic inflammation compared to saline-exposed controls. - Source: PubMed
Publication date: 2026/07/02
Llinás-Caballero KevinAcevedo NathalieMerid Simon KebedeDonado KarenEspinoza HectorMondol ErnestoReina RandyRegino RonaldBenedetti InésZakzuk JosefinaPuerta LeonardoMelén ErikCaraballo Luis - Glaucoma, a leading cause of irreversible blindness, is a complex polygenic disease where significant clinical and genetic heterogeneity do not explain all glaucoma cases, highlighting the need for a deeper understanding of molecular mechanisms like epigenetics. This review examines the emerging role of key epigenetic mechanisms, specifically DNA methylation, histone modifications, and non-coding RNAs in glaucoma pathogenesis and their potential as biomarkers and therapeutic targets. We discuss how aberrant DNA methylation (e.g., hypomethylation/ hypermethylation) promotes trabecular meshwork fibrosis and increases optic nerve vulnerability, contributing to disease development and/or progression. The histone methylation linked to retinal ganglion cell death at normal eye pressure, and disease-specific microRNA profiles further support the role of epigenetic involvement in glaucoma. The proof-of-concept studies of GDF7 neutralization in primate models and the OSK-factor reprogramming in aged and glaucoma mice models, show that epigenetic changes are reversible and can restore visual functions. DNA methylation-based epigenetic clocks identify glaucoma as an accelerated molecular aging process. Although promising, the current evidences are largely preclinical and long-term human data are still lacking. Nonetheless, the inherent reversible nature of epigenetics offers significant translational potential. Methylation, epigenetic clocks, and circulating microRNA profiles could enable early, non-invasive biomarkers for diagnosis and prognosis. Future efforts are needed to validate biomarkers in large cohorts and develop targeted epigenetic therapies. In conclusion, epigenetics is redefining our current understanding of glaucoma from a pressure-based disease to a modifiable link between genes and environment paving the way for personalized care for vision preservation beyond pressure-lowering treatments. - Source: PubMed
Publication date: 2026/02/23
Kondkar Altaf ASultan TahiraAzad Taif AAl-Obeidan Saleh A